<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">606178848</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20210128100758.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">210128e20151201xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s11136-015-1038-z</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s11136-015-1038-z</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Phantipa Sakthong, Nontapat Sonsa-ardjit, Pattarin Sukarnjanaset, Wipaporn Munpan]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Purpose: Due to the problem of high ceiling effects of the EQ-5D-3L, the EQ-5D-5L was developed. However, little was known about the full psychometric properties of the EQ-5D-5L. Thus, this study aimed to evaluate its practicality, reliability, validity, and responsiveness in Thai patients with chronic diseases. Methods: One thousand one hundred and fifty-six adults taking a medicine at least 3months were identified from three university hospitals in Bangkok, Thailand, between July 2014 and March 2015. Practicality was evaluated by administration times and ceiling effects. Test-retest reliability was assessed using weighted kappa and intraclass correlation coefficients (ICCs). Validity was tested with correlations between the EQ-5D-5L and WHOQoL-BREF and SF-12v2, and known-groups validity. Responsiveness was measured with standardized effect sizes (SES). Results: The mean administration time was approximately 2min, and the ceiling effect of the EQ-5D-5L index was 13.6%. The weighted kappa values and ICC of the EQ-5D-5L were 0.48-0.61 and 0.82, respectively. Similar dimensions of the EQ-5D-5L had higher correlations with those of WHOQoL-BREF and SF-12v2. As expected, elderly, female, low-educated, unemployed, higher number of comorbidities and medicines, patients' perception of poor disease control, and having an adverse drug reaction tended to have poorer EQ-5D-5L scores. The SES of EQ-5D-5L index and EQ-VAS were considered small (0.33-0.42) for the improved group. For the worsened group, the SES of the EQ-5D-5L index were considered small (−0.29) but that of the EQ-VAS considered large (−0.82). Conclusions: The EQ-5D-5L was practical, reliable, valid, and responsive in Thai patients with chronic diseases.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer International Publishing Switzerland, 2015</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">EQ-5D-5L</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Psychometrics</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Reliability</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Validity</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Responsiveness</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Thailand</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Sakthong</subfield>
   <subfield code="D">Phantipa</subfield>
   <subfield code="u">Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Sonsa-ardjit</subfield>
   <subfield code="D">Nontapat</subfield>
   <subfield code="u">Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Sukarnjanaset</subfield>
   <subfield code="D">Pattarin</subfield>
   <subfield code="u">Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Munpan</subfield>
   <subfield code="D">Wipaporn</subfield>
   <subfield code="u">Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Quality of Life Research</subfield>
   <subfield code="d">Springer International Publishing</subfield>
   <subfield code="g">24/12(2015-12-01), 3015-3022</subfield>
   <subfield code="x">0962-9343</subfield>
   <subfield code="q">24:12&lt;3015</subfield>
   <subfield code="1">2015</subfield>
   <subfield code="2">24</subfield>
   <subfield code="o">11136</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s11136-015-1038-z</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s11136-015-1038-z</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Sakthong</subfield>
   <subfield code="D">Phantipa</subfield>
   <subfield code="u">Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Sonsa-ardjit</subfield>
   <subfield code="D">Nontapat</subfield>
   <subfield code="u">Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Sukarnjanaset</subfield>
   <subfield code="D">Pattarin</subfield>
   <subfield code="u">Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Munpan</subfield>
   <subfield code="D">Wipaporn</subfield>
   <subfield code="u">Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Quality of Life Research</subfield>
   <subfield code="d">Springer International Publishing</subfield>
   <subfield code="g">24/12(2015-12-01), 3015-3022</subfield>
   <subfield code="x">0962-9343</subfield>
   <subfield code="q">24:12&lt;3015</subfield>
   <subfield code="1">2015</subfield>
   <subfield code="2">24</subfield>
   <subfield code="o">11136</subfield>
  </datafield>
 </record>
</collection>
